Navigation Links
EndoSphere Inc. Announces Pivotal Financing Led by Broadline Capital
Date:6/1/2011

COLUMBUS, Ohio, June 1, 2011 /PRNewswire/ -- EndoSphere Inc., a medical technology company developing a platform of endoscopically implantable devices for the treatment of metabolic diseases, including obesity and type 2 diabetes, announced today the completion of a highly oversubscribed Series A Preferred Financing round led by Broadline Capital, a global private equity investment firm.  EndoSphere Inc., which holds 23 U.S. and international issued and pending patents, will use the funding to expand its intellectual property assets and to complete additional clinical product testing.

"EndoSphere is extremely fortunate to align itself with Broadline Capital, which offers a rare blend of global financial expertise and pragmatic operating experience," said James McKinley, EndoSphere CEO.

Broadline Capital was formed in 2005 by Christopher Thorne, an early pioneer in China's private equity industry and former management consultant at McKinsey & Company.  Thorne previously founded and developed a software technology company that created efficiency gains for manufacturers, distributors and retailers in the trillion-dollar food and beverage, consumer packaged goods and retail supply chains.  The resulting company sold to institutional investors at a nine-figure enterprise valuation in 2007.

"An investment in EndoSphere presented us with a unique opportunity to invest in, and support, an exciting portfolio of intellectual property assets and a highly experienced management team," said Thorne. "EndoSphere's technology brings an innovative approach to treating obesity, which has become one of the largest health problems worldwide."

The company is planning a multi-center clinical trial while continuing its research and development of innovative and profitable applications.  

"With the support of this financing, EndoSphere is poised to fulfill the potential of the technology and the expectations of the investors,"
'/>"/>

SOURCE EndoSphere Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... San MediTech, the industry leader in China ... announced its plan to attend the American Diabetes Association ... on June 5 th to 8 th ... (DGMS). The company plans to show industry experts and ... advancements made by Chinese medical device companies. San MediTech ...
(Date:6/2/2015)... -- CytRx Corporation (NASDAQ: CYTR ), a biopharmaceutical research ... it has reached an agreement to settle the stockholder ... Court of Chancery, which names as defendants a ... officers, and names the Company as a nominal defendant. ... Corp. Stockholder Derivative Litigation , C.A. No. 9864-VCL, relates ...
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/jrlgdj/electrophysiology ) ... Market by Product {Diagnostic Catheter (Conventional, Advanced, Ultrasound)), ... Recording, Generator, ICE, X-ray)) & Indication (AF, VT, ... to their offering. The global electrophysiology ... significant CAGR of 10.3% from 2014 to 2019 ...
Breaking Medicine Technology:San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 2San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 3San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 4CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 3CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 4Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 2Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 3
... 16, 2011 Misonix, Inc. (Nasdaq: ... manufactures, and markets innovative, therapeutic, ultrasonic products worldwide ... laparoscopic surgery, and other surgical and medical applications, ... with the exception of certain selected accounts, of ...
... 2011 Netsmart Technologies, Inc., a leading provider ... services organizations, has been presented with the National ... Year Award. Each March during ... recognizes a premier member that has demonstrated a ...
Cached Medicine Technology:Misonix Announces Change in Distribution of BoneScalpel™ Bone Cutting System in the U.S. 2Misonix Announces Change in Distribution of BoneScalpel™ Bone Cutting System in the U.S. 3Netsmart Technologies Named NACo Premier Partner of the Year 2Netsmart Technologies Named NACo Premier Partner of the Year 3
(Date:6/2/2015)... Viejo, CA (PRWEB) June 02, 2015 TranSlice: ... with a new style. TranSlice: Reveal allows Final Cut Pro ... and growing lines to reveal their next screen. , TranSlice ... unique style. Final Cut Pro X users can ... and growing lines. , With every panel orientation and direction ...
(Date:6/2/2015)... Amercanex, the American Cannabis Exchange, ... become Amercanex’s new Chief Technology Officer. Amercanex is ... cultivators, wholesale distributors and retail vendors can buy, ... transparent intra-state market. , Jim Miller is an ... space, helping innovative technology companies deliver on their ...
(Date:6/2/2015)... June 02, 2015 Thermi, formerly ... company has successfully transitioned into its new company ... to the company’s continued rapid worldwide expansion and ... of over 25 Thermi employees, including those of ... teams. , “As one of the fastest growing ...
(Date:6/2/2015)... Atlantic Spine Center , a ... three locations in New Jersey, announces the opening of ... facility is at 1045 Park Avenue (at East 86th ... can be arranged by calling 1-844-912-2406. , Dr. ... Center, has been a pioneer in the development of ...
(Date:6/2/2015)... June 02, 2015 Specialty Technical ... compliance and risk solutions , and Radar today ... management effectiveness gap-improvement program. , All organizations need ... on objectives. Organizations not only assess and treat ... to do this (risk managing) thereby embedding these ...
Breaking Medicine News(10 mins):Health News:Announcing the release of TranSlice Reveal from Pixel Film Studios - Professional Split Screen Transitions for FCPX. 2Health News:Amercanex Names Jim Miller to CTO Position 2Health News:Thermi Moves to New Corporate Headquarters as Rapid Company Expansion Continues 2Health News:Renowned Endoscopic Spine Surgeon Dr. Kaixuan Liu Announces Opening of Park Avenue Office 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 3Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 4
... , Feb. 16 In these difficult times in ... bringing money and services into the Reno area.   ... Start Learning Disabilities Programs Inc. is providing cutting edge educational and ... The $200,000.00 represents a net investment into the area. ...
... University researchers have developed a hands-free alternative to cell phone ... doing it, make it safer," said Juan Gilbert, professor and ... Computing. He said one problem with banning texting while ... He said it will be difficult for police to can,t ...
... radiological evidence suggest broken leg, malaria and genetic disorder ... King Tut probably wasn,t killed by a vengeful wife ... a broken leg and several inherited disorders that rendered ... new DNA and radiological evidence suggests. , "What ...
... Washington, DC Combining tamoxifen, the world,s most prescribed breast ... feverfew may prevent initial or future resistance to the drug, ... reported online in FASEB Feb. 12, provides ... also tests a novel way to get around it. "A ...
... them with a laser has been shown to be a ... occur in places where a laser light can,t reach? Scientists ... directing gold nanoparticles into the nuclei of cancer cells, they ... them where they lurk. The research appeared as a communication ...
... peer-reviewed international journal of the American Cancer Society, ... in its Jan. 1 edition, demonstrating disparities in ... white women. The HealthCore study reiterates ... populations using government health programs that African-American ...
Cached Medicine News:Health News:Reno Children With Disabilities Profit From a Little Known but Internationally Recognized Non-Profit Organization as it Quietly Crosses the $200,000.00 Mark in Service Investment Into the Reno Area 2Health News:King Tut's Demise Gets New Explanation 2Health News:King Tut's Demise Gets New Explanation 3Health News:GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen 2Health News:GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen 3Health News:Using gold nanoparticles to hit cancer where it hurts 2Health News:Cancer publishes study confirming disparity in breast cancer treatment 2
For reconstruction, trauma and chronic stenosis of canalicular system. Medical grade silicone tubing (tapered at one end). Blue polypropylene suture. Box of 3, sterile....
Recommended to insert plug portion of all monocanalicular intubation systems into punctum....
For proper plug sizing....
For proper plug sizing....
Medicine Products: